C.S. Mott Hospital
Ann Arbor, Michigan, 48109, United States
NCT Number: NCT03382119
The goal of this study is to determine if ultrasound tools can be used to detect liver stiffness. Acoustic radiation force impulse (ARFI) elastography and backscatter will be used to see if they can detect liver stiffness in different populations of patients with liver disease.
The study is measuring liver stiffness in pediatric patients aged 2-5 years. Patients either have had a Fontan cardiac surgery or have liver disease.
Ultrasound scanning takes images of the liver and has much lower risks for patients. ARFI elastography and other tools can be used to measure liver stiffness.
Looking for future studies?
Notify Me2 year–5 year
All sexes
Observational
Ann Arbor, Michigan, 48109, United States
If patients have liver congestion, reversing it could prevent liver fibrosis, which cannot be treated. Liver fibrosis has serious health risks and is associated with a higher chance of developing liver cancer later in life.
Subjects from two patient populations will be enrolled in order to test ultrasound technologies. A total of 30 subjects between 2-5 years of age will be enrolled.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
This technology uses sound waves to measure the stiffness of tissue.
Other names: elastography
This ultrasound tool gathers data from the waves returning from imaged tissue.
Time frame: 15 minutes
Shear wave speed is a measure of stiffness of liver tissue expressed in units of m/s
University of Michigan
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04785937
Digestive System Diseases, Fatty Liver
Reggio Emilia, RE, Italy
View Trial DetailsNCT04682600
Digestive System Diseases, Fatty Liver
Boston, Massachusetts, United States
View Trial DetailsNCT03149627
Alcohol-Induced Disorders, Alcohol-Related Disorders
Lusaka, Zambia
View Trial DetailsNCT03483584
Avitaminosis, Bone Diseases
Shatin, Hong Kong
View Trial Details